Column Capital Advisors’s Qiagen QGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
$1.18K Hold
27
﹤0.01% 723
2023
Q2
$1.31K Hold
27
﹤0.01% 738
2023
Q1
$1.33K Hold
27
﹤0.01% 751
2022
Q4
$1.45K Hold
27
﹤0.01% 730
2022
Q3
$1K Hold
27
﹤0.01% 694
2022
Q2
$1K Hold
27
﹤0.01% 695
2022
Q1
$1K Hold
27
﹤0.01% 699
2021
Q4
$2K Hold
27
﹤0.01% 671
2021
Q3
$1K Hold
27
﹤0.01% 693
2021
Q2
$1K Hold
27
﹤0.01% 690
2021
Q1
$1K Hold
27
﹤0.01% 680
2020
Q4
$2K Hold
27
﹤0.01% 615
2020
Q3
$2K Hold
27
﹤0.01% 605
2020
Q2
$1K Buy
+27
New +$1.21K ﹤0.01% 781

Other funds holding QGEN

Column Capital Advisors's QGEN Position: Q3 2023 in Review

Column Capital Advisors held its Qiagen (QGEN) position steady in Q3 2023 at 27 shares worth $1.18K. The position accounts for ﹤0.01% of the portfolio, ranked #723.

Column Capital Advisors first reported a position in QGEN in Q2 2020 and has held it in 14 quarters since. The position peaked at $2K in Q4 2021. 278 funds tracked by Wall St. Rank hold QGEN as of Q3 2023.

  • Column Capital Advisors held 27 shares of Qiagen worth $1.18K as of Q3 2023.
  • Column Capital Advisors left its Qiagen share count unchanged in Q3 2023.
  • Qiagen made up ﹤0.01% of Column Capital Advisors's portfolio in Q3 2023, its #723 holding.
  • Column Capital Advisors first reported a position in Qiagen in Q2 2020 and has held it in 14 quarters since.
  • Column Capital Advisors's Qiagen position peaked at $2K in Q4 2021.
  • 278 funds tracked by Wall St. Rank held Qiagen as of Q3 2023.

Based on Column Capital Advisors's 13F filing for Q3 2023, filed 3 Nov 2023.